Skip to main content
. 2017 Apr 11;7:812. doi: 10.1038/s41598-017-00845-x

Figure 1.

Figure 1

TGF-β induces an increase in levels of PTEN and its phosphorylation in human TM cells. (A,B) Real-time PCR analysis of COL1A1 and PTEN mRNA levels in TM cells treated with TGF-β2 (1 or 5 ng/ml). RNA was extracted at 12 and 24 h. mRNA expression levels were normalized to EUK18S. A two-way ANOVA with Bonferroni’s post-hoc was used to determine statistical significance. *p < 0.05, **p < 0.01, ****p < 0.0001. N = 3. (C,D) Western blot analysis of collagen levels in TM cells treated with TGF-β (T1, T5, T10 indicates 1, 5 or 10 ng/ml TGF-β2). Protein was extracted at 24 and 48 h. TGF-β receptor signaling was inhibited using the inhibitor SB431542 (SB; 20 μM). D7278- representative human donor. (E,F) Western blot analysis of PTEN levels and its phosphorylation (pPTEN- ser380/thr382/383) in TM cells treated with TGF-β and SB431542. Protein was extracted at 24 and 48 h. D7278- representative human donor. (G,H) Densitometry was performed on PTEN and pPTEN Western blot data at 48 h using ImageJ software. Statistical significance was determined using one-way ANOVA with Tukey’s post-hoc. *p < 0.05, **p < 0.01, ***p < 0.001. N = 3. (I,J). TGF-β-mediated induction of PTEN levels and its phosphorylation was confirmed in TM cells from an adult human donor, aged 26 yrs (Adult 26Y).